Total Payments
$375,728
2024 Payments
$21,996
Companies
39
Transactions
870
Medicare Patients
18,118
Medicare Billing
$2.9M
Payment Breakdown by Category
Other$325,345 (86.6%)
Food & Beverage$25,073 (6.7%)
Travel$24,456 (6.5%)
Consulting$801.00 (0.2%)
Education$53.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $325,345 | 143 | 86.6% |
| Food and Beverage | $25,073 | 672 | 6.7% |
| Travel and Lodging | $24,456 | 46 | 6.5% |
| Consulting Fee | $801.00 | 3 | 0.2% |
| Education | $53.21 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $122,926 | 178 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $121,026 | 162 | $0 (2023) |
| Amgen Inc. | $46,426 | 138 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39,895 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $24,753 | 74 | $0 (2024) |
| Boston Scientific Corporation | $9,386 | 30 | $0 (2024) |
| Lilly USA, LLC | $5,330 | 3 | $0 (2024) |
| Abbott Laboratories | $1,429 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,361 | 78 | $0 (2024) |
| Amarin Pharma Inc. | $403.38 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,996 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,551) |
| 2023 | $13,641 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,852) |
| 2022 | $9,507 | 57 | Amgen Inc. ($6,474) |
| 2021 | $13,970 | 65 | AstraZeneca Pharmaceuticals LP ($12,895) |
| 2020 | $23,530 | 69 | AstraZeneca Pharmaceuticals LP ($8,807) |
| 2019 | $71,117 | 136 | Novartis Pharmaceuticals Corporation ($26,867) |
| 2018 | $61,297 | 176 | Novartis Pharmaceuticals Corporation ($24,818) |
| 2017 | $160,668 | 251 | Janssen Pharmaceuticals, Inc ($79,527) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Boston Scientific Corporation | myLUX Patient Kit with mobile device (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: myLUX_CRM | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Stryker Corporation | 1788 (Medical Supply) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: ENDOSCOPY | ||||||
| 10/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $39.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Not Applicable | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,744 | 6,310 | $3.6M | $577,618 |
| 2022 | 29 | 4,702 | 7,961 | $4.7M | $749,593 |
| 2021 | 28 | 5,303 | 9,383 | $4.5M | $879,947 |
| 2020 | 23 | 4,369 | 7,742 | $3.7M | $671,162 |
Total Patients
18,118
Total Services
31,396
Medicare Billing
$2.9M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,226 | 3,215 | $1.7M | $327,482 | 19.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 281 | 321 | $256,800 | $48,011 | 18.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 241 | 243 | $430,110 | $40,899 | 9.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 198 | 540 | $156,600 | $36,983 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 382 | $145,160 | $27,299 | 18.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 384 | 422 | $173,620 | $24,150 | 13.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 79 | 79 | $379,990 | $19,987 | 5.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 85 | 103 | $76,220 | $14,781 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $57,420 | $11,391 | 19.8% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 25 | 25 | $67,500 | $8,029 | 11.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 363 | 423 | $38,070 | $5,100 | 13.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 75 | 75 | $51,750 | $4,863 | 9.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $10,790 | $2,313 | 21.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 18 | $10,440 | $1,623 | 15.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 78 | 78 | $9,360 | $1,395 | 14.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 121 | 123 | $27,060 | $1,336 | 4.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 78 | 78 | $7,020 | $925.08 | 13.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 32 | 45 | $2,700 | $712.80 | 26.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 19 | $1,900 | $285.00 | 15.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 20 | 21 | $420.00 | $54.18 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,139 | 2,848 | $1.5M | $284,522 | 18.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 234 | 234 | $888,780 | $91,806 | 10.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 313 | 345 | $276,000 | $58,141 | 21.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 233 | 466 | $146,760 | $45,925 | 31.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 247 | 248 | $436,140 | $43,175 | 9.9% |
About Dr. Inderpal Singh, MD
Dr. Inderpal Singh, MD is a Cardiovascular Disease healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104829738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Inderpal Singh, MD has received a total of $375,728 in payments from pharmaceutical and medical device companies, with $21,996 received in 2024. These payments were reported across 870 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($325,345).
As a Medicare-enrolled provider, Singh has provided services to 18,118 Medicare beneficiaries, totaling 31,396 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Goshen, NY
- Active Since 05/27/2005
- Last Updated 10/18/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1104829738
Products in Payments
- ENTRESTO (Drug) $122,811
- XARELTO (Drug) $121,007
- Repatha (Biological) $45,676
- JARDIANCE (Drug) $29,963
- FARXIGA (Drug) $23,878
- PRADAXA (Drug) $15,262
- WATCHMAN (Device) $9,023
- ELIQUIS (Drug) $1,402
- BRILINTA (Drug) $875.19
- Corlanor (Drug) $659.36
- SCS IPGs (Device) $619.62
- Vascepa (Drug) $403.38
- INTELLIS (Device) $285.72
- Impella (Device) $235.27
- SCS leads (Device) $185.96
- OPTIMIZER (Device) $182.97
- MITRACLIP (Device) $167.50
- NORTHERA (Drug) $152.53
- Mitra Clip system (Device) $145.59
- PRALUENT (Biological) $145.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Goshen
Blair Macphail, Md, MD
Cardiovascular Disease — Payments: $11,130
Cardiovascular Disease $11,130
Dr. Farid Jalinous, M.d, M.D
Cardiovascular Disease — Payments: $8,841
Cardiovascular Disease $8,841
Dr. Djavid Hadian, M.d, M.D
Cardiovascular Disease — Payments: $6,566
Cardiovascular Disease $6,566
Dr. Viral Sheth, Md, MD
Cardiovascular Disease — Payments: $3,853
Cardiovascular Disease $3,853
Sreenivas Kamath, Md, MD
Cardiovascular Disease — Payments: $3,339
Cardiovascular Disease $3,339
Dr. Hratch Kazanjian, M.d, M.D
Cardiovascular Disease — Payments: $3,161
Cardiovascular Disease $3,161